{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:45:09Z","timestamp":1793123109322,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T00:00:00Z","timestamp":1609286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"German Research Foundation DFG","award":["STR 387\/4-2"],"award-info":[{"award-number":["STR 387\/4-2"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,21]]},"abstract":"Abstract<\/jats:title>\n \n BACKGROUND<\/jats:title>\n IVM was implemented in medically assisted reproduction 25\u2009years ago. IVM does not involve controlled ovarian stimulation (COS) and is mainly indicated in patients with a high risk of ovarian hyperstimulation syndrome, in particular in patients with polycystic ovary syndrome (PCOS); it is also an acknowledged option in fertility protection. However, the in-vitro culture of immature oocytes raises concerns over their developmental potential and the putative impact on children\u2019s health. Although an increasing number of studies on obstetric and neonatal outcomes of IVM children and their development have been published in recent years, study designs are difficult to compare, since IVM is used in women with various indications and IVM protocols do not follow the same standards.<\/jats:p>\n <\/jats:sec>\n \n OBJECTIVE AND RATIONALE<\/jats:title>\n The aim of this systematic review was to evaluate the current evidence from IVM children of an impact of in-vitro culture of immature oocytes. Primary outcome parameters were birthweight and children\u2019s development up to the age of 2\u2009years. We also compared pregnancy pathologies and the outcome of IVM children and COS children in relation to maternal indications, in particular PCOS, and to the type of IVM protocols with or without ovulation trigger as the secondary outcome parameters. IVM is an accepted clinical option for many centres; however, a comprehensive analysis of the available data is needed to establish whether the use of human oocytes that are fully matured in vitro is safe for both children and their mothers.<\/jats:p>\n <\/jats:sec>\n \n SEARCH METHODS<\/jats:title>\n Google Scholar and PubMed were used for identifying peer-reviewed original articles and reviews through January 2020. A total of 191 studies were screened and 16 studies were included in the qualitative synthesis. Studies were stratified according to indications, the use of an ovulation trigger and multiplicity.<\/jats:p>\n <\/jats:sec>\n \n OUTCOMES<\/jats:title>\n Birthweights of IVM singletons and multiples were comparable to their respective COS controls: birthweights were also similar if the analysis was restricted to mothers with PCOS. IVM children had a comparable birthweight to COS children, irrespective of whether an ovulation trigger was used in IVM cycles or not. The frequency of gestational diabetes (GD) in singleton pregnancies was comparable between IVM and COS, regardless of infertility background. There was also no difference in GD frequency between IVM and COS, if an hCG ovulation trigger in IVM cycles was used or not. Hypertensive disorders in singleton pregnancies of women with PCOS were significantly more frequent after IVM compared to COS, in particular if IVM cycles were performed only with in-vitro matured oocytes. There was no difference in the preterm birth rate of singleton pregnancies between IVM and COS. Preterm birth rates were still similar if only women diagnosed with PCOS were compared and whether an ovulation trigger in IVM was used or not. The malformation rate in IVM children did not differ in COS children versus children after natural conception. At the age of 2\u2009years, IVM singletons showed similar anthropometric and mental development compared to COS children or children from natural conception.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS<\/jats:title>\n The higher incidence of hypertensive disorders in IVM pregnancies needs monitoring during pregnancy. Current data on the development of IVM children are encouraging, although the quality of many studies is limited and long-term data beyond 2\u2009years are scarce. Further studies should be based on generally accepted IVM protocols. Studies on long-term outcomes beyond 2\u2009years are needed to search for potential long-time sequelae of IVM.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humupd\/dmaa056","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T23:44:52Z","timestamp":1606261492000},"page":"460-473","source":"Crossref","is-referenced-by-count":19,"title":["Maternal and neonatal outcome and children\u2019s development after medically assisted reproduction with in-vitro<\/i> matured oocytes\u2014a systematic review and meta-analysis"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7024-855X","authenticated-orcid":false,"given":"Thomas","family":"Strowitzki","sequence":"first","affiliation":[{"name":"Department of Gynecological Endocrinology and Reproductive Medicine, Heidelberg University, 69121 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bruckner","sequence":"additional","affiliation":[{"name":"Institute for Medical Biometry and Informatics, Heidelberg University, 69121 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Roesner","sequence":"additional","affiliation":[{"name":"Department of Gynecological Endocrinology and Reproductive Medicine, Heidelberg University, 69121 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,30]]},"reference":[{"key":"2021042605535077100_dmaa056-B1","first-page":"hoz043","article-title":"Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndrome","volume":"2020","author":"Belva","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2021042605535077100_dmaa056-B2","first-page":"135","article-title":"The health of children conceived by ART: \u2018the chicken or the egg?","volume":"27","author":"Berntsen","year":"2019","journal-title":"Hum Reprod Update"},{"key":"2021042605535077100_dmaa056-B3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/humrep\/deh592","article-title":"A multi-centre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception","volume":"20","author":"Bonduelle","year":"2005","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/humupd\/dmaa011","article-title":"Risk of gestational diabetes mellitus in women achieving singleton pregnancy spontaneously or after ART: a systematic review and meta-analysis","volume":"26","author":"Bosdou","year":"2020","journal-title":"Hum Reprod Update"},{"key":"2021042605535077100_dmaa056-B5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000284627.38540.80","article-title":"Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization and intracytoplasmic sperm injection","volume":"110","author":"Buckett","year":"2007","journal-title":"Obstet Gynecol"},{"key":"2021042605535077100_dmaa056-B6","doi-asserted-by":"crossref","first-page":"1700106","DOI":"10.1002\/bies.201700106","article-title":"DNA methylation in embryo development: epigenetic impact of ART (assisted reproductive technologies)","volume":"39","author":"Canovas","year":"2017","journal-title":"Bioessays"},{"key":"2021042605535077100_dmaa056-B7","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.fertnstert.2004.11.044","article-title":"Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer","volume":"83","author":"Cha","year":"2005","journal-title":"Fertil Steril"},{"key":"2021042605535077100_dmaa056-B8","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0015-0282(00)00422-2","article-title":"Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome","volume":"73","author":"Cha","year":"2000","journal-title":"Fertil Steril"},{"key":"2021042605535077100_dmaa056-B9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0015-0282(16)54068-0","article-title":"Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program","volume":"55","author":"Cha","year":"1991","journal-title":"Fertil Steril"},{"key":"2021042605535077100_dmaa056-B10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/humrep\/15.1.165","article-title":"Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome","volume":"15","author":"Chian","year":"2000","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B11","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJM199911183412118","article-title":"Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome","volume":"341","author":"Chian","year":"1999","journal-title":"N Engl J Med"},{"key":"2021042605535077100_dmaa056-B12","first-page":"15","article-title":"Obstetric outcomes and congenital abnormalities in infants conceived with oocytes matured in vitro","volume":"6","author":"Chian","year":"2014","journal-title":"Facts Views Vis ObGyn"},{"key":"2021042605535077100_dmaa056-B13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/humrep\/dey242","article-title":"ART in Europe, 2014: results generated from European registries by ESHRE","volume":"33","author":"de Geyter","year":"2018","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B14","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/dew208","article-title":"The definition of IVM is clear-variations need defining","volume":"31","author":"De Vos","year":"2016","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(14)60834-5","article-title":"Fertility preservation in women with cancer","volume":"384","author":"De Vos","year":"2014","journal-title":"Lancet"},{"key":"2021042605535077100_dmaa056-B16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(65)92903-X","article-title":"Maturation in vitro of human ovarian oocytes","volume":"286","author":"Edwards","year":"1965","journal-title":"Lancet"},{"key":"2021042605535077100_dmaa056-B17","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1093\/humrep\/des359","article-title":"Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births form conventional ICSI cycles","volume":"27","author":"Fadini","year":"2012","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B18","doi-asserted-by":"crossref","first-page":"e89713","DOI":"10.1371\/journal.pone.0089713","article-title":"Growth development of French children born after in vitro maturation","volume":"9","author":"Foix-L\u2019H\u00e9lias","year":"2014","journal-title":"PLoS One"},{"key":"2021042605535077100_dmaa056-B19","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s10815-018-1317-z","article-title":"In vitro maturation (IVM) of oocytes in patients with resistant ovary syndrome and in patients with repeated deficient oocyte maturation","volume":"35","author":"Galv\u00e3o","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"2021042605535077100_dmaa056-B20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/uog.18932","article-title":"Congenital heart defects in IVF\/ICSI pregnancy: systematic review and meta-analysis","volume":"51","author":"Giorgione","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2021042605535077100_dmaa056-B21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.fertnstert.2016.12.007","article-title":"Cardiovascular and metabolic profiles of offspring conceived by assisted reproductive technologies: a systematic review and meta-analysis","volume":"107","author":"Guo","year":"2017","journal-title":"Fertil Steril"},{"key":"2021042605535077100_dmaa056-B22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/humupd\/dmt006","article-title":"Assisted reproductive technology and birth defects: a systematic review and meta-analysis","volume":"19","author":"Hansen","year":"2013","journal-title":"Hum Reprod Update"},{"key":"2021042605535077100_dmaa056-B23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/aogs.13347","article-title":"Trends over time in congenital malformations in live-born children conceived after assisted reproductive technology","volume":"97","author":"Henningsen","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2021042605535077100_dmaa056-B24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/humrep\/dez060","article-title":"The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count","volume":"34","author":"Ho","year":"2019","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3961\/jpmph.16.122","article-title":"Congenital malformations in infants of mothers undergoing assisted reproductive technologies: a systematic review and meta-analysis study","volume":"50","author":"Hoorsan","year":"2017","journal-title":"J Prev Med Public Health"},{"key":"2021042605535077100_dmaa056-B8554765","volume-title":"Annual Report","year":"2011"},{"key":"2021042605535077100_dmaa056-B26","first-page":"1","article-title":"Determinants of infant birthweights","volume":"40","year":"1997","journal-title":"K J Ob Gyn"},{"key":"2021042605535077100_dmaa056-B27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/humupd\/dmx031","article-title":"Is frozen embryo transfer better for mothers and babies? Can cumulative metaanalysis provide a definitive answer?","volume":"24","author":"Maheshwari","year":"2018","journal-title":"Hum Reprod Update"},{"key":"2021042605535077100_dmaa056-B28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1472-6483(10)61666-5","article-title":"Strategies in human in-vitro maturation and their clinical outcome","volume":"10","author":"Mikkelsen","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"2021042605535077100_dmaa056-B29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/rep.0.1220587","article-title":"Benefit of FSH priming of women with PCOS to the in-vitro maturation procedure and the outcome. A randomized prospective study","volume":"122","author":"Mikkelsen","year":"2001","journal-title":"Reproduction"},{"key":"2021042605535077100_dmaa056-B30","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/humrep\/dez086","article-title":"Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation","volume":"34","author":"Mostinckx","year":"2019","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B31","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/humrep\/dev090","article-title":"Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group","volume":"30","author":"Opdahl","year":"2015","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/humupd\/dms018","article-title":"Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF\/ICSI: a systematic review and meta-analysis","volume":"18","author":"Pandey","year":"2012","journal-title":"Hum Reprod Update"},{"key":"2021042605535077100_dmaa056-B33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/humupd\/dms044","article-title":"Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis","volume":"19","author":"Pinborg","year":"2013","journal-title":"Hum Reprod Update"},{"key":"2021042605535077100_dmaa056-B34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1084\/jem.62.5.665","article-title":"The comparative behavior of mammalian eggs in vivo and in vitro: I. the activation of ovarian eggs","volume":"62","author":"Pincus","year":"1935","journal-title":"J Exp Med"},{"key":"2021042605535077100_dmaa056-B35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/humrep\/det463","article-title":"Beyond the dichotomy: a tool for distinguishing between experimental, innovative and established treatment","volume":"29","author":"Provoost","year":"2014","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00404-016-4250-3","article-title":"Worldwide prevalence of adverse pregnancy outcomes among singleton pregnancies after in vitro fertilization\/intracytoplasmic sperm injection: a systematic review and metaanalysis","volume":"295","author":"Qin","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"2021042605535077100_dmaa056-B37","volume-title":"Bayley Scales of Infant Development","author":"Reuner","year":"2008","edition":"2nd edn."},{"key":"2021042605535077100_dmaa056-B38","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/humrep\/dex068","article-title":"Two-year development of children conceived by IVM: a prospective study","volume":"32","author":"Roesner","year":"2017","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/OGX.0000000000000150","article-title":"In vitro maturation and its role in clinical assisted reproductive technology","volume":"70","author":"Sauerbrun-Cutler","year":"2015","journal-title":"Obstet Gynecol Surv"},{"key":"2021042605535077100_dmaa056-B40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.rbmo.2019.03.203","article-title":"A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF","volume":"39","author":"Sha","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"2021042605535077100_dmaa056-B41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.earlhumdev.2006.01.012","article-title":"Growth and development of children conceived by in-vitro maturation of human oocytes","volume":"82","author":"Shu-Chi","year":"2006","journal-title":"Early Hum Dev"},{"key":"2021042605535077100_dmaa056-B42","first-page":"CD006606","article-title":"In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction","volume":"11","author":"Siristatidis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2021042605535077100_dmaa056-B43","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/humrep\/dei503","article-title":"Obstetric and perinatal outcome and preliminary results of development of children born after in vitro maturation of oocytes","volume":"21","author":"S\u00f6derstr\u00f6m-Anttila","year":"2006","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1472-6483(10)60294-5","article-title":"Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved","volume":"17","author":"Son","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"2021042605535077100_dmaa056-B45","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/humrep\/15.4.747","article-title":"Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery, maturation and fertilization of immature human oocytes","volume":"15","author":"Suikkari","year":"2000","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B46","first-page":"23","article-title":"In Vitro fertilization technology and child health: risks, mechanisms and possible consequences","volume":"117","author":"von Wolff","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"2021042605535077100_dmaa056-B47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/humrep\/deu248","article-title":"In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes","volume":"30","author":"Walls","year":"2015","journal-title":"Hum Reprod"},{"key":"2021042605535077100_dmaa056-B48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10815-013-9945-9","article-title":"Quality evaluation of IVM embryo and imprinting genes of IVM babies","volume":"30","author":"Yoshida","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"2021042605535077100_dmaa056-B49","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.fertnstert.2019.05.034","article-title":"Obstetrical, neonatal, and long-term outcomes of children conceived from in vitro matured oocytes","volume":"112","author":"Yu","year":"2019","journal-title":"Fertil Steril"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/27\/3\/460\/37248782\/dmaa056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/27\/3\/460\/37248782\/dmaa056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T05:55:32Z","timestamp":1619416532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/27\/3\/460\/6055418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,30]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,12,30]]},"published-print":{"date-parts":[[2021,4,21]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmaa056","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2020,12,30]]}}}